Gordon Naylor
-
CSL Leadership Shifts: Gordon Naylor Named Interim CEO After McKenzie Retires
Australian biopharmaceutical giant CSL Limited has appointed Gordon Naylor as interim CEO and Managing Director, effective February 11, 2026, following the retirement of Paul McKenzie. The move aims to ensure continuity during the search for a permanent successor.
-
CSL Names Interim CEO After McKenzie’s Departure
Australian biopharmaceutical giant CSL has appointed Gordon Naylor as interim CEO and managing director, following the immediate departure of Paul McKenzie. The leadership change comes as the company navigates a significant strategic transformation and faces scrutiny over its recent share…